Bombesin receptor antagonists. 3. Irreversible alkylating analogues: melphalan derivatives. 1991

R de Castiglione, and L Gozzini, and M Galantino, and F Corradi, and E Arlandini, and I Molinari, and M Ciomei
Farmitalia Carlo Erba S.r.l.-Erbamont Group, Milano, Italy.

Bombesin (BN)-like peptides (such as GRP, gastrin-releasing peptide) are autocrine growth factors for small cell lung carcinoma (SCLC). BN receptor antagonists can therefore find clinical application in the treatment of this highly malignant disease. The present paper deals with a new class of bombesin analogues carrying a nitrogen mustard at their N-terminus. Due to the irreversible binding to the BN receptor(s), these peptides eventually block the mitogenic effects of the natural ligand(s), regardless of their intrinsic "agonistic" or "antagonistic" structures. In Swiss 3T3 fibroblasts they inhibit [125I]GRP binding in the nanomolar/micromolar range. According to their "agonistic" or "antagonistic" structural features, they do or do not induce [3H]thymidine incorporation and p 115 phosphorylation. In competition experiments, alkylating "antagonists" selectively inhibit BN-induced thymidine incorporation either when given simultaneously with or 24 hours before the BN challenge. Alkylating "agonists" display antagonistic effects only in the sequential treatment.

UI MeSH Term Description Entries
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D017981 Receptors, Neurotransmitter Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behavior of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses. Neurohumor Receptors,Neuromediator Receptors,Neuromodulator Receptors,Neuroregulator Receptors,Receptors, Neurohumor,Receptors, Synaptic,Synaptic Receptor,Synaptic Receptors,Neuromediator Receptor,Neuromodulator Receptor,Neuroregulator Receptor,Neurotransmitter Receptor,Receptors, Neuromediators,Receptors, Neuromodulators,Receptors, Neuroregulators,Receptors, Neurotransmitters,Neuromediators Receptors,Neuromodulators Receptors,Neuroregulators Receptors,Neurotransmitter Receptors,Neurotransmitters Receptors,Receptor, Neuromediator,Receptor, Neuromodulator,Receptor, Neuroregulator,Receptor, Neurotransmitter,Receptor, Synaptic,Receptors, Neuromediator,Receptors, Neuromodulator,Receptors, Neuroregulator
D018004 Receptors, Bombesin Cell surface proteins that bind bombesin or closely related peptides with high affinity and trigger intracellular changes influencing the behavior of cells. Gastrin- releasing peptide (GRP); GRP 18-27 (neuromedin C), and neuromedin B are endogenous ligands of bombesin receptors in mammals. Bombesin Receptors,Gastrin-Releasing Peptide Receptors,Neuromedin B Receptors,Receptors, Gastrin-Releasing Peptide,Receptors, Neuromedin B,Bombesin Receptor,Gastrin-Releasing Peptide Receptor,Neuromedin B Receptor,B Receptor, Neuromedin,B Receptors, Neuromedin,Gastrin Releasing Peptide Receptor,Gastrin Releasing Peptide Receptors,Peptide Receptor, Gastrin-Releasing,Peptide Receptors, Gastrin-Releasing,Receptor, Bombesin,Receptor, Gastrin-Releasing Peptide,Receptor, Neuromedin B,Receptors, Gastrin Releasing Peptide

Related Publications

R de Castiglione, and L Gozzini, and M Galantino, and F Corradi, and E Arlandini, and I Molinari, and M Ciomei
March 1987, The American journal of physiology,
R de Castiglione, and L Gozzini, and M Galantino, and F Corradi, and E Arlandini, and I Molinari, and M Ciomei
January 1988, Synapse (New York, N.Y.),
R de Castiglione, and L Gozzini, and M Galantino, and F Corradi, and E Arlandini, and I Molinari, and M Ciomei
January 1991, Peptides,
R de Castiglione, and L Gozzini, and M Galantino, and F Corradi, and E Arlandini, and I Molinari, and M Ciomei
September 1987, Journal of medicinal chemistry,
R de Castiglione, and L Gozzini, and M Galantino, and F Corradi, and E Arlandini, and I Molinari, and M Ciomei
September 1990, The Journal of biological chemistry,
R de Castiglione, and L Gozzini, and M Galantino, and F Corradi, and E Arlandini, and I Molinari, and M Ciomei
September 1990, The American journal of physiology,
R de Castiglione, and L Gozzini, and M Galantino, and F Corradi, and E Arlandini, and I Molinari, and M Ciomei
January 1986, NIDA research monograph,
R de Castiglione, and L Gozzini, and M Galantino, and F Corradi, and E Arlandini, and I Molinari, and M Ciomei
April 1993, European journal of pharmacology,
R de Castiglione, and L Gozzini, and M Galantino, and F Corradi, and E Arlandini, and I Molinari, and M Ciomei
January 1988, Peptides,
R de Castiglione, and L Gozzini, and M Galantino, and F Corradi, and E Arlandini, and I Molinari, and M Ciomei
April 1976, Life sciences,
Copied contents to your clipboard!